Our State Of Healthcare report features data-driven insights from our emerging tech insights platform. We take a look at global healthcare investment trends in key verticals, top deals, active investors, and more.
Q2’21 marked another record quarter for global healthcare investment as digital transformation initiatives accelerated.
Key themes that emerged over the quarter included a growing focus on the patient experience, rising awareness of health inequities, and heightening pressure for telehealth regulatory reform.
In this report, we feature updates on global healthcare funding, M&A deals, partnership activity, and technology that’s gaining traction. Our quarterly report also covers trends within specific areas of healthcare, including AI in healthcare, telehealth, medical devices, digital therapeutics, mental health, omics, and health IT.
- Global healthcare investment rose for the seventh consecutive quarter, albeit at a slower pace. Funding surpassed $34.7B across nearly 1.6K deals. The acceleration of digital transformation initiatives was a major contributor, with digital health startups accounting for 40% of both the deals and funding raised in the quarter ($14.1B across 628 deals).
- European investment nearly doubled quarter-over-quarter (QoQ) to reach $6.9B. Q2’21 was the fifth quarter in a row to see QoQ European investment growth. Asian investment fell for the second quarter in a row, though at $7.4B, it remained elevated vs. pre-Q3’20 levels.
- A flood of new entrants pushed early-stage deal share above 50%. Coming in at 54% of global healthcare deals, early-stage deal share was the highest it’s been since Q3’19.
- Eleven healthcare startups joined the unicorn club during Q2’21 (valued in aggregate at $27B). Globally there are currently 78 healthcare unicorns valued in aggregate at $214B.